Other News

Heart Muscle Tissue Chips Among Life Science Investigations Launching to ISS on SpaceX CRS-27

KENNEDY SPACE CENTER, Fla., March 8, 2023 /PRNewswire/ — Two tissue chip investigations funded by the National Institutes of Health (NIH) are among the payloads launching on SpaceX’s 27th Commercial Resupply Services (CRS) mission to the International Space Station (ISS). These projects, sponsored by the ISS National Laboratory, will study microgravity’s effects on engineered […]

New Study Highlights Wide Disparities in Access to Life-Saving Mechanical Thrombectomy Stroke Treatment

Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study investigated the determinants of mechanical thrombectomy access for stroke globally WASHINGTON, March 8, 2023 /PRNewswire/ — The Society of Vascular and Interventional Neurology (SVIN) has released a first-ever global analysis of access to mechanical thrombectomy (MT) for treatment of large […]

AdventHealth Opens Dedicated Heart Failure Unit to Provide More Advanced Monitoring to Patients

The new unit at AdventHealth Tampa’s Pepin Heart Institute allows cardiologists to provide advanced therapies that improve outcomes for patients. TAMPA, Fla., March 8, 2023 /PRNewswire/ — AdventHealth Tampa announced a new 20-bed unit dedicated to patients diagnosed with heart failure. The disease affects one in five people over age 40, according […]

Argon Medical Devices Modernizes Portal Vein Access with the Launch of the TRAVELER™ Series

PLANO, Texas, March 7, 2023 /PRNewswire/ — Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology, introduces the TRAVELER™ Portal Vein Access Series as the newest addition to its portal vein access product portfolio. The product line is designed to meet the challenging needs of […]

FLAME Study Demonstrates 90% Survival Improvement in High-Risk Pulmonary Embolism with Inari Medical FlowTriever System

IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary embolism (“PE”). The data was […]

Restore Medical Announces Successful First-In-Human Preliminary Results of Its CONTRABAND™ System for Symptomatic Systolic Heart Failure Patients

OR YEHUDA, Israel, March 7, 2023 /PRNewswire/ — Restore Medical Ltd, a privately held medical device company, has successfully completed enrollment of the First In Human clinical study with its CONTRABAND™ device. The world’s first and only Pulmonary Artery Banding (PAB) transcatheter implant is designed to treat heart failure with reduced ejection fraction (HFrEF) and […]

Biosense Webster’s First Dual Energy Catheter to Treat Atrial Fibrillation Begins Evaluation in SmartfIRE Clinical Trial

Study will evaluate THERMOCOOL SMARTTOUCH™ SF Dual Energy Catheter’s potential to enable safer and simpler procedures with the ability to deliver both radiofrequency and pulsed field ablation Irvine, CA – March 7, 2023 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced […]

Neovasc Shareholders Approve Acquisition by Shockwave Medical

VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, is pleased to announce that its Shareholders (as defined below) have approved the previously-announced acquisition of all […]

Powerful Medical Launches PMcardio in the UK, Empowering Healthcare Professionals to Diagnose and Treat Cardiovascular Diseases with AI

LONDON, March 07, 2023 (GLOBE NEWSWIRE) — Powerful Medical is thrilled to announce the release of PMcardio, a revolutionary clinical assistant powered by artificial intelligence in the United Kingdom. The unique medical device in the form of a smartphone application empowers healthcare professionals to diagnose and treat 38 cardiovascular diseases from […]

Amarin Announces Board Departures

DUBLIN, Ireland and BRIDGEWATER. N.J., March 06, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that, in the interest of the Company to avoid further proxy contests, all seven independent non-Sarissa board members: Adam Berger, Erin Enright, Geraldine Murphy, Kristine Peterson, Dr. Murray […]